~~<i id='B238892D97'><strike id='B238892D97'><tt id='B238892D97'><pre id='B238892D97'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：entertainment 2025-10-06 13:17:03 Page View：4

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview
Next article： Tori Bowie and the unacceptable rates of Black maternal death

focus

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

eGenesis tests gene

Agene-editedYucatanminipigcreatedbyeGenesis.CourtesyLizLinder/eGenesisForthreedaysinDecember,anICUro

Virginia high school admissions case could be legal follow

3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

Independent physicians launch a new lobbying group

PaulBerggreen,agastroenterologistatArizonaDigestiveHealthwhoformedanewlobbyinggroupforindependentphy